STOCK TITAN
  1. Home
  2. SURF

Surface Oncology Stock Price, News & Analysis

SURF NASDAQ

Company Description

Surface Oncology (NASDAQ: SURF) is a publicly traded research and development in biotechnology company in the Professional, Scientific, and Technical Services sector.

SURF stock has declined 100.0% over the past year.

This page provides a comprehensive overview of SURF stock, including real-time price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.

Stock Performance

Chart
$—
0.00%
0.00
Last updated:
-100%
Performance 1 year
$0.0
Market Cap
60.8M
Shares outstanding

Surface Oncology (SURF) stock. Over the past 12 months, the stock has lost 100.0%.

Latest News

View All
August 2, 2023
-5.93%

Surface Oncology Reports Financial Results and Corporate Highlights for Second Quarter 2023

earnings
June 16, 2023
+6.99%

Coherus to Acquire Surface Oncology

acquisition
May 4, 2023
-0.43%

Surface Oncology Reports Financial Results and Corporate Highlights for First Quarter 2023

earnings
April 18, 2023
0.00%

Surface Oncology Presents New Preclinical Data on SRF114, a fully human anti-CCR8 antibody, at the AACR Annual Meeting 2023

clinical trial
March 16, 2023
+4.84%

Surface Oncology to Present New Preclinical SRF114 Data at the American Association for Cancer Research (AACR) Annual Meeting 2023 

conferences
March 9, 2023
+12.40%

Surface Oncology Reports Financial Results and Corporate Highlights for Fourth Quarter and Full Year 2022

earnings

Surface Oncology has 10 recent news articles. Of the recent coverage, 6 articles coincided with positive price movement and 3 with negative movement. Key topics include earnings, acquisition, clinical trial, conferences. View all SURF news →

SEC Filings

View All

No SEC filings available for SURF.

Financial Highlights

View Full Financials
—
Revenue (TTM)
—
Net Income (TTM)
—
Diluted EPS (TTM)
—
Operating Cash Flow
—
Net Profit Margin
—
Oper. Profit Margin

Upcoming Events

Short Interest History

Last 12 Months

Days to Cover History

Last 12 Months

SURF Company Profile & Sector Positioning

Surface Oncology (SURF) operates in the Research and Development in Biotechnology industry within the broader Professional, Scientific, and Technical Services sector and is listed on the NASDAQ.